Verastem (VSTM) in Focus: Stock Rises by 7.3%

Zacks

Verastem, Inc. (VSTM) was a big mover last session, as the company saw its shares rise by over 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company, as the stock is now up nearly 14% in the past one-month time frame.

This biopharmaceutical company has seen a mixed track record when it comes to estimate revision. Two estimates each have moved up and down over the last one month, while its Zacks Consensus Estimate moved lower over the same time frame. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Verastem currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.

However, better-ranked stocks in the same industry include Heska Corporation (HSKA), Vanda Pharmaceuticals, Inc. (VNDA) and Threshold Pharmaceuticals Inc. (THLD). While Heska Corp. and Vanda Pharmaceuticals hold a Zacks Rank #1 (Strong Buy), Threshold Pharmaceuticals carries a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>





VERASTEM INC (VSTM): Free Stock Analysis Report

HESKA CORP (HSKA): Free Stock Analysis Report

VANDA PHARMACEUTICALS INC (VNDA): Free Stock Analysis Report

THRESHOLD PHARMACEUTICALS INC (THLD): Free Stock Analysis Report


Zacks Investment Research

View Comments (0)